Metoprolol Zot Stada (Metoprolol Tartrate)

Metoprolol Tartrate is a selective β1‑adrenergic receptor antagonist. By blocking these receptors in the heart, it reduces heart rate, myocardial contractility, and cardiac output. The drug also lowers renin release from the kidneys, contributing to a decrease in blood pressure and overall cardiac workload.

The appropriate dose of Metoprolol Zot Stada is determined by the prescribing healthcare professional based on the patient’s specific condition, age, kidney and liver function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for Metoprolol Zot Stada in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Metoprolol Zot Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardio‑selective (β1‑selective) beta blocker, offering advantages in patients with respiratory conditions compared with non‑selective agents. Compared with other β1‑selective drugs like atenolol, metoprolol has a shorter half‑life and may require twice‑daily dosing, but it provides similar efficacy for hypertension and heart failure.

Metoprolol Zot Stada should be stored at room temperature, below 25 °C, in its original container. Keep the product away from excess moisture, heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Metoprolol Zot Stada is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water. The dosing schedule (once or twice daily) depends on the clinical indication and the individual’s response.

Serious risks include severe bradycardia, marked hypotension, heart block, worsening heart failure, bronchospasm in patients with asthma or COPD, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, severe shortness of breath, or signs of an allergic reaction.

Metoprolol Zot Stada is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, cardiogenic shock, or overt decompensated heart failure. Caution is also advised for individuals with severe asthma, COPD, or uncontrolled peripheral vascular disease.